EG20048A - Process for preparing of 2-(4- hydroxypiperidino)-1-alkanol derivatives as antischemic agents - Google Patents

Process for preparing of 2-(4- hydroxypiperidino)-1-alkanol derivatives as antischemic agents

Info

Publication number
EG20048A
EG20048A EG39792A EG39792A EG20048A EG 20048 A EG20048 A EG 20048A EG 39792 A EG39792 A EG 39792A EG 39792 A EG39792 A EG 39792A EG 20048 A EG20048 A EG 20048A
Authority
EG
Egypt
Prior art keywords
antischemic
hydroxypiperidino
agents
preparing
alkanol derivatives
Prior art date
Application number
EG39792A
Other languages
English (en)
Inventor
Willard M Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20048A publication Critical patent/EG20048A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG39792A 1991-07-17 1992-07-16 Process for preparing of 2-(4- hydroxypiperidino)-1-alkanol derivatives as antischemic agents EG20048A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
EG20048A true EG20048A (en) 1997-03-27

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
EG39792A EG20048A (en) 1991-07-17 1992-07-16 Process for preparing of 2-(4- hydroxypiperidino)-1-alkanol derivatives as antischemic agents

Country Status (22)

Country Link
EP (1) EP0594729A1 (enExample)
JP (1) JP2571904B2 (enExample)
KR (1) KR0165003B1 (enExample)
CN (1) CN1043759C (enExample)
AU (1) AU655840B2 (enExample)
BR (1) BR9206272A (enExample)
CA (1) CA2113568A1 (enExample)
CZ (1) CZ284133B6 (enExample)
EG (1) EG20048A (enExample)
FI (2) FI981956L (enExample)
HU (1) HUT70528A (enExample)
IE (1) IE922311A1 (enExample)
IL (1) IL102473A (enExample)
MX (1) MX9204190A (enExample)
NO (1) NO180445C (enExample)
NZ (1) NZ243580A (enExample)
PL (1) PL169884B1 (enExample)
PT (1) PT100689B (enExample)
RU (1) RU2065859C1 (enExample)
TW (1) TW201732B (enExample)
WO (1) WO1993002052A1 (enExample)
ZA (1) ZA925306B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
PL173618B1 (pl) * 1992-10-30 1998-04-30 Pfizer Związki 6-[2-(4-hydroksy-4-fenylopiperydyno)-1-hydroksypropylo]-3,4-dihydro-2(1H)-chinolonowe
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US6978166B2 (en) 1994-10-07 2005-12-20 Saint Louis University System for use in displaying images of a body part
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
CA2369695A1 (en) * 1999-04-09 2000-10-19 Manabu Itoh Agent for treating neuropathic pain
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
MXPA03007621A (es) 2001-02-23 2003-12-04 Merck & Co Inc Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
EP1390034A4 (en) 2001-04-03 2005-07-13 Merck & Co Inc N-SUBSTITUTED NONARYL HETEROCYCLO AMIDYL-NMDA / NR2B ANTAGONISTS
US7494987B2 (en) 2002-11-25 2009-02-24 Mochida Pharmaceutical Co., Ltd. Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient
MXPA06003748A (es) * 2003-10-08 2006-06-14 Pfizer Compuestos de lactama condensada.
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途
BR112022025900A2 (pt) * 2020-06-23 2023-01-10 Biohaven Therapeutics Ltd Formulações tópicas de (1s)-1-fenil-2-piridin-2-iletanamina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
EP0554247B1 (en) * 1990-05-10 2000-04-26 Pfizer Inc. Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
FI940192A0 (fi) 1994-01-14
NZ243580A (en) 1994-10-26
CN1068566A (zh) 1993-02-03
NO180445B (no) 1997-01-13
CN1043759C (zh) 1999-06-23
JP2571904B2 (ja) 1997-01-16
RU2065859C1 (ru) 1996-08-27
PT100689A (pt) 1993-10-29
EP0594729A1 (en) 1994-05-04
IL102473A (en) 1997-07-13
NO180445C (no) 1997-04-23
JPH06504293A (ja) 1994-05-19
CZ284133B6 (cs) 1998-08-12
BR9206272A (pt) 1995-04-11
IE922311A1 (en) 1993-01-27
NO940144D0 (no) 1994-01-14
ZA925306B (en) 1994-01-17
FI981956A0 (fi) 1998-09-11
CZ400892A3 (en) 1994-03-16
FI940192L (fi) 1994-01-14
IL102473A0 (en) 1993-01-14
PT100689B (pt) 1999-06-30
FI981956A7 (fi) 1998-09-11
TW201732B (enExample) 1993-03-11
CA2113568A1 (en) 1993-02-04
MX9204190A (es) 1993-01-01
KR0165003B1 (en) 1999-01-15
FI981956L (fi) 1998-09-11
WO1993002052A1 (en) 1993-02-04
FI940192A7 (fi) 1994-01-14
HUT70528A (en) 1995-10-30
AU655840B2 (en) 1995-01-12
PL169884B1 (pl) 1996-09-30
AU2322592A (en) 1993-02-23
NO940144L (no) 1994-01-14
HU9400136D0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
IL102473A0 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
ZA918636B (en) Process for the preparation of piperazine derivatives
EP0523671A3 (en) Process for the preparation of chlorofluoronitrobenzenes
EP0457730A3 (en) Process for preparation of thioderivatives of alkylhydroxyanilinotriazine
GR910100427A (en) Process for preparing 8-chloroquinolone derivatives
HUT69309A (en) Process for the preparation of 2-alkoxymethyl-acrolein
EP0476649A3 (en) Process for the preparation of carbapeneme compounds
EG21612A (en) Process for preparing of naphtoqunone derivatives
EP0537589A3 (en) Process for the preparation of dinitro- and diaminophenoxy compounds
EP0703229A3 (en) Process for the preparation of 3-amino-5-methoxychroman
EP0518013A3 (en) Process for the preparation of 1-alkoxy-2-dialkylaminoethanes
EP0503603A3 (en) Process for preparing 2-exo-methylene-penam derivatives
IL105779A0 (en) Methods for the preparation of oxazole derivatives
HRP920125A2 (en) Process for the preparation of novel arylaminocarbonyl compounds
NZ243690A (en) Process for the preparation of 13-<alpha>-cinnamoylbaccatine iii derivatives
EP0523668A3 (en) Process for the preparation of difluorobenzaldehydes
EP0547414A3 (en) Process for the preparation of n-substituted nitro-p-phenylenediamines
IL103922A0 (en) Process for the preparation of trifluorobenzene derivatives
HU9401981D0 (en) Process for preparation of chloro-methyl-pyridin derivatives
CS145892A3 (en) Process for preparing spiroisoquinoline pyrrolidine derivatives
EP0483061A3 (en) Process for the preparation of 4-(3-fluoro-pyridine-2-yloxy)-phenoxy-propionic acids
ZA91378B (en) Process for the preparation of pyrazolecarboxylic acid derivatives
GB9205920D0 (en) Process for the preparation of pyrethroide derivatives
EP0526793A3 (en) Process for the preparation of diphenylamines
EG19619A (en) Process for preparing oxazole derivatives